Literature DB >> 18304700

[Thymic carcinoid tumor revealed by a Cushing's syndrome: usefulness of positron emission tomography].

E Gomard-Mennesson1, P Sève, E De La Roche, S Collardeau-Frachon, C Lombard-Bohas, C Broussolle.   

Abstract

Ectopic adrenocorticotropic (ACTH) syndrome is a rare condition, generally due to lung or carcinoid tumors. 18-fluorodeoxy-glucose positron emission tomography ((18)FDG-PET) can be useful where conventional localization techniques often fail. A 50-year-old man presented with sudden diffuse oedema, hypokaliemic alkalosis, Diabetes mellitus and high serum levels of ACTH and cortisol. Ectopic ACTH syndrome was confirmed leading to ketoconazole treatment. Chest-computed tomography only revealed an aspecific anterior mediastinal nodule that was hypermetabolic on the whole body-(18)FDG-PET. A thymic tumor was suspected and the patient had a thymectomy that revealed an atypical carcinoid tumor with pleural carcinosis. The postoperative course was favorable with clinical and biochemical remission of neoplastic Cushing's syndrome.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18304700     DOI: 10.1016/j.revmed.2008.01.007

Source DB:  PubMed          Journal:  Rev Med Interne        ISSN: 0248-8663            Impact factor:   0.728


  3 in total

1.  Cushing syndrome secondary to ectopic adrenocorticotropic hormone secretion: the University of Texas MD Anderson Cancer Center Experience.

Authors:  Shamim Ejaz; Rena Vassilopoulou-Sellin; Naifa L Busaidy; Mimi I Hu; Steven G Waguespack; Camilo Jimenez; Anita K Ying; Maria Cabanillas; Maher Abbara; Mouhammed Amir Habra
Journal:  Cancer       Date:  2011-03-15       Impact factor: 6.860

2.  The role of integrated (18)F-FDG PET/CT in identification of ectopic ACTH secretion tumors.

Authors:  Haoping Xu; Min Zhang; Ge Zhai; Miao Zhang; Guang Ning; Biao Li
Journal:  Endocrine       Date:  2009-10-06       Impact factor: 3.633

Review 3.  18F-fluorodihydroxyphenylalanine vs other radiopharmaceuticals for imaging neuroendocrine tumours according to their type.

Authors:  Sona Balogova; Jean-Noël Talbot; Valérie Nataf; Laure Michaud; Virginie Huchet; Khaldoun Kerrou; Françoise Montravers
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-02-16       Impact factor: 9.236

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.